Phillip A Sharp insider trades

Open-market stock purchases and sales by Phillip A Sharp, Director at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 10, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ALNY Alnylam Pharmaceuticals, Inc: 22 sales, last Jan 23, 2025
  • VIR Vir Biotechnology, Inc: other filings, last May 22, 2023
  • SYRS Syros Pharmaceuticals, Inc: other filings, last Jun 1, 2022

Get free alerts when Phillip A Sharp files a new trade →